About: Targeting PI3KCA pathway to improve patient outcomes in hormone receptor-positive breast cancer: a worthy 20-year wager?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Targeting PI3KCA pathway to improve patient outcomes in hormone receptor-positive breast cancer: a worthy 20-year wager? Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття (uk) article scientifique publié en 2019 (fr)
publication date	wds:Q94233481-F6E70041-0BA4-43C7-AD8F-8CEBD345EB57
publication date	2019-12-20 00:00:00Z (xsd:dateTime)
cites work	wds:Q94233481-09579DA6-1591-4EBE-B34C-9275831A4BBD wds:Q94233481-20EC4124-B0CB-4854-8574-068DBC8CD46E wds:Q94233481-2F0A8358-9E46-4741-8BB0-9A9933AFF82F wds:Q94233481-505E4F89-516B-4F29-8685-901D4598FFE0 wds:Q94233481-81EDBDB6-3C4E-46DD-A7A3-0FEEB49EA9D9 wds:Q94233481-C2EE9F6D-4EC8-44F0-9992-80A1D2AC722C wds:Q94233481-F383B02A-B63F-47F1-A833-1413A826FB07 wds:Q94233481-F918A416-C235-4B65-BF61-5F0B34EE6679 wds:Q94233481-FE8166F6-F95A-46E6-BF01-4B05FFF2570F
cites work	Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer. MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy. Palbociclib and Letrozole in Advanced Breast Cancer Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3 Cancer statistics, 2018. MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer. Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer
author name string	wds:Q94233481-1A939FAE-F968-4D21-997E-DA266157A11C
author name string	C Saura
rdfs:label	Targeting PI3KCA pathway to improve patient outcomes in hormone receptor-positive breast cancer: a worthy 20-year wager? (en) Targeting PI3KCA pathway to improve patient outcomes in hormone receptor-positive breast cancer: a worthy 20-year wager? (nl)
skos:prefLabel	Targeting PI3KCA pathway to improve patient outcomes in hormone receptor-positive breast cancer: a worthy 20-year wager? (en) Targeting PI3KCA pathway to improve patient outcomes in hormone receptor-positive breast cancer: a worthy 20-year wager? (nl)
name	Targeting PI3KCA pathway to improve patient outcomes in hormone receptor-positive breast cancer: a worthy 20-year wager? (en) Targeting PI3KCA pathway to improve patient outcomes in hormone receptor-positive breast cancer: a worthy 20-year wager? (nl)
title	wds:Q94233481-DEE1AE42-0BA8-462E-BA28-72A8B2FCDCED
title	Targeting PI3KCA pathway to improve patient outcomes in hormone receptor-positive breast cancer: a worthy 20-year wager? (en)
page(s)	wds:Q94233481-B1FF13B5-28B2-409B-B4AE-09AEFA9474B2
page(s)	x1-x2
instance of	wds:Q94233481-1906425D-8AFC-4D68-8E26-0818D7D38103
instance of	scholarly article
published in	wds:Q94233481-1B5057CB-7B74-471E-8612-9EF985A3ADB5
published in	Annals of Oncology
issue	wds:Q94233481-14F63519-257F-4117-A3CF-CA163B0F1CD1
volume	wds:Q94233481-3416F8F6-1274-412C-ABBC-6DCAE53BE827
issue	Suppl 10
volume	30
DOI	wds:Q94233481-786BC944-432C-44AB-A2C8-C1208A1F60D2
DOI	http://dx.doi.org/10.1093/ANNONC/MDZ439
DOI	10.1093/ANNONC/MDZ439
PMCID	wds:Q94233481-C13718BD-39CC-459E-91D8-6D2D4E282FD5
PMCID	6923784
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q94233481

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 194 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software